Preferable II
Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors
Latest news
15/09/2025 - Event
7th consortium meeting in Heidelberg
Last week, our international consortium met in Heidelberg to exchange updates and ideas. We shared our experiences with recruitment across site and we held an interdisciplinary working group on the opportunities and challenges of working across different fields and countries.
30/04/2025 - News
PREFERABLE-II Joins the MovingBeyond Conference
This April, members of the PREFERABLE-II team joined the MovingBeyond Conference in Lisbon, Portugal — an inspiring international event focused on how exercise can help people with cancer. Researchers, doctors, and patients came together to share the latest insights and experiences from around the world.
Collaboration
PREFERABLE II consists of an international consortium of twelve academic partners, one cutting edge game development and software engineering SME, an academic clinical research organisation and one European patient organisation (European Cancer Patient Coalition). The partners are from seven countries: the Netherlands, Germany, Sweden, Portugal, Spain, UK and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.
Our partners
